Pemberian Dini Vasopresor pada Syok Sepsis

Ferianto Ferianto, Ezra Oktaliansah, Indriasari Indriasari

Abstract

Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection and become one of leading causes of death in Intensive Care Unit (ICU). The two components of treating sepsis shock are fluid resuscitation and administration of vasopressor. Early administration of vasopressor in conjunction with fluid administration can reduce mortality because it reduces the volume of resuscitation so as to prevent excess fluid in the patient. Recent recommendation from  Surviving Sepsis Campaign (SSC) suggest fluid resuscitation and medication within the first 1 hour including vasopressor administration in concomitant life-threatening cases of hyptension or immediately after fluid resuscitation to maintain MAP level ≥ 65mmHg. Holistic treatment will reduce the mortality of patient with sepsis shock in the ICU

Keywords

Sepsis, sepsis shock, ICU, vasopressor, Surviving Sepsis Campaign (SSC)

Full Text:

PDF

References

Yang RL. Taryn BB. CCSAP BOOK 1 septic management . 2019.7-31.

Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 2017.

Kadri SS, Rhee C, Strich JR, et al. Estimating ten-year trends in septic shock incidence and mortality in United States academic medical centers using clinical data. Chest 2017;151:278-85.

Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs. claims data, 2009-2014. JAMA 2017;218:1241-9.

Menteri Kesehatan Republik Indonesia. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Sepsis. Nomor Hk.01.07/Menkes/342/2017. 2017

Minasyam H. Septic and septic shock: pathogenesis and treatment perspective: researchgate. Journal of Critical Care 2017;40:229-42.

Pangalila FJU, Mansjoer A. Penatalaksanaan sepsis dan shock septik. Jakarta; PERDICI, 2017.

Meier-Hellmann A, Specht M, Hannemann L et al. Splanchnic flow is greater in septic shock treated with norepinephrine than in severe sepsis. Int Care Med. 1996; 22 :1354–9.

Di Giantomasso D, May CN, Bellomo R. Norepinephrine and vital organ blood flow.Int Care Med 2002; 28: 1804–9.

Martin C, Viviand X, Arnaud S et al. Effects of norepinephrine plus dobutamineor norepinephrine alone on left ventricular performance of septic shock patients. Crit Care Med 1999; 7 : 1708–13.

Day NP, Phu NH, Bethell DP et al. The effects of dopamine and adrenaline infusions on acid–base balance and systemic haemodynamics in severe infections. Lancet 1996; 348 : 219–223.

De Backer D, Aldecoa C, Njimi H, VincentJL. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med 2012; 40 : 725–30.

Vasu TS, Cavallazzi R, Hirani A et al.Norepinephrine or dopamine for septic shock: a systematic review of randomized controlled trials. J Intensive Care Med 2012; 27 : 172–8.

Dellinger RP, Levy MM, Rhodes A et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41 : 580–637.

Devins SS, Miller A, Herndon BL et al. Effects of dopamine on T-lymphocyte proliferative responses and serum prolacti concentrations in critically ill patients. Crit Care Med 1992; 20 : 1644–9.

Neviere R, Mathieu D, Chagnon JL et al. The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Resp and Crit Care Med 1996; 154 : 1684–8

Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 2017;43:304e377.

Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med 2018;44:925e928.

Permpikul C, Tongyoo S, Viarasilpa T, et al. Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) : A Randomized Trial. Am J Respir Crit Care Med 2019;199:1097e1105.

Bai X, Yu W, Ji W, et al. Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care 2014;18:532.

Hamzaoui O, Georger J-F, Monnet X, et al. Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care 2010; 14:R142.

Georger J-F, Hamzaoui O, Chaari A, et al. Restoring arterial pressure with norepinephrine improves muscle tissue oxygenation assessed by near-infrared spectroscopy in severely hypotensive septic patients. Intensive Care Med 2010;36:1882e1889.

Sennoun N, Montemont C, Gibot S, et al. Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock. Crit Care Med 2007;35:1736e1740.

Lankadeva YR, Kosaka J, Evans RG, et al. Intrarenal and urinary oxygenation during norepinephrine resuscitation in ovine septic acute kidney injury. Kidney Int 2016;90:100e108.

Subramanian S, Yilmaz M, Rehman A, et al. Liberal vs. Conservative vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: an observational study. Intensive Care Med 2008;34:157e162.

Persichini R, Silva S, Teboul J-L, et al. Effects of norepinephrine on mean systemic pressure and venous return in human septic shock. Crit Care Med 2012;40:3146e3153.

Hinder F, Stubbe HD, Van Aken H, et al. Early multiple organ failure after recurrent endotoxemia in the presence of vasoconstrictormasked hypovolemia. Crit Care Med 2003;31:903e909.

Mamta Patel,Fang Gao Smith . Vasoactive Drugs. Cambridge University Press 2019

Shields, SH Holland. Pharmacology of Vasopressors and Inotropes, Tintinalli’s emergency medicine a comprehensive study guide, 8 edn, mcgraw-hill education, United States, pp.143-146

DOI: https://doi.org/10.26891/JIK.v14i2.2020.69-80

Refbacks

  • There are currently no refbacks.